10-May-2001 - Royal DSM N.V. (Koninklijke DSM N.V.)

DSM Biologics aims for global leadership position among independent contract manufacturers for the pharmaceutical industry

DSM Biologics, a business unit of the DSM Fine Chemicals business group, today brought on stream a new 2,000-litre fermentation unit at its Montreal (Quebec, Canada) site for the preparation of biopharmaceuticals on the basis of cell cultures. This new CAN 9 million unit, which was officially opened by Peter Elverding, chairman of the DSM Managing Board, is DSM Biologics' response to the increased demand for fermentation capacity, in particular for the preparation of biopharmaceutical products. The new fermentation unit consists of clean rooms and a fermentor train. The fermentor train consists of two seed fermentors of 50 and 320 litres for culturing cells and a 2,000-litre production fermentor. DSM Biologics amply meets the quality standards set by the pharmaceutical industry (cGMP). The DSM Biologics site in Montreal is jointly owned by DSM and Societé générale de financement du Québec (SGF).

Ambitions

The fact that the new unit was officially opened by DSM Managing Board chairman Peter Elverding underlined the importance of the role played by DSM Biologics' ambitions in DSM's transformation into a specialty company. The ceremony was also attended by representatives of the Province of Quebec, which supports the establishment and development of advanced biotechnological industries in the Montreal region.

In his speech Peter Elverding made reference to the strong growth in the market for biopharmaceutical products. "Some 30% of all new pharmaceutical products in clinical trial are currently made on the basis of biopharmaceutical technologies," he said.

Current global capacity for biopharmaceutical contract manufacturing is not capable of meeting future demand. Three years ago sales were about CAN 300 million. Within the next five years the market is expected to grow to around CAN 2 billion.

Société générale de financement du Québec

The mission of the Société générale de financement du Québec is, in cooperation with partners and under conditions of normal profitability, to carry out economic development projects. Since its restructuring in 1998, SGF has generated investments of close to CAN 4.4 billion and created over 19,400 direct and indirect jobs in projects that have reached the operating stage, without counting the thousands of jobs created during the construction stage. As at September 30, 2000, the consolidated assets of SGF ran at over CAN 2.2 billion. SGF has 52 international partners carrying out operations in Quebec.

Facts, background information, dossiers
  • DSM
  • fermentation
  • Société Générale
  • biopharmaceuticals
More about DSM
  • News

    Covestro to acquire sustainable coating resins business from DSM

    Covestro has signed an agreement to acquire the Resins & Functional Materials business (RFM) from Royal DSM. By expanding its portfolio in the attractive growth market for sustainable coating resins, Covestro is taking a significant step in its long-term corporate strategy to strengthen its ... more

    DSM and NHU inaugurate joint venture to produce high performance PPS compounds

    Royal DSM and specialty chemicals producer Zhejiang NHU Special Materials Co., Ltd. (NHU), have officially inaugurated their joint venture company for polyphenylene sulfide (PPS) compounds, DSM NHU Engineering Plastics (Zhejiang) Co Ltd., on August 22nd. The JV, which was announced May 2015 ... more

    DSM and CVC finalize partnership for Polymer Intermediates and Composite Resins

    Royal DSM and CVC Capital Partners (CVC) announced that the partnership for DSM's activities in Polymer Intermediates (Caprolactam and Acrylonitrile) and Composite Resins through the formation of a new company, ChemicaInvest B.V., has been finalized. With all regulatory approvals now receiv ... more

  • Companies

    DSM Corporate ICT

    DSM creates innovative products and services in Life Sciences and Materials Sciences, contributing to the quality of life. DSM’s products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and enjoyable way of living. End mar ... more

    DSM Fine Chemicals

    DSM creates innovative products and services in Life Sciences and Materials Sciences, contributing to the quality of life. DSM’s products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and enjoyable way of living. End mar ... more

    DSM Desotech Inc.

    DSM creates innovative products and services in Life Sciences and Materials Sciences, contributing to the quality of life. DSM’s products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and enjoyable way of living. End mar ... more